Forge Biologics · 1 day ago
Summer Intern - Manufacturing Science & Technology (MS&T)
Forge Biologics is dedicated to enabling access to life-changing gene therapies. The Manufacturing Science & Technology (MS&T) Intern will support process development and technology transfer activities, gaining hands-on experience in a GMP environment.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Assist MS&T scientists with process monitoring and data analysis to ensure consistency and compliance
Assist with client-facing functional Lead for Process Technology Transfers by performing detailed review of clients and Process Development process and generate technology transfer documents
Participate in process characterization studies, including sampling and data collection
Collaborate with cross-functional teams to identify and implement efficiency improvements
Gain exposure to bioprocessing principles (upstream and downstream) and analytical techniques used in gene therapy manufacturing
Qualification
Required
Incoming junior or senior for Summer 2026, currently enrolled in a full-time bachelor's degree program at an accredited college or university
Minimum 3.0 GPA or equivalent
Majoring in Biology, Biotechnology, Chemical Engineering, Biochemistry, or related life sciences field
Strong attention to detail, organizational skills, and thrive working in a collaborative environment
Interest in data analysis, problem-solving, and process optimization
Company
Forge Biologics
Forge Biologics is a gene therapy development engine, enabling access to life changing gene therapy programs.
H1B Sponsorship
Forge Biologics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (7)
2024 (4)
2023 (2)
2022 (1)
Funding
Current Stage
Growth StageTotal Funding
$330MKey Investors
State of OhioMidCap FinancialRA Capital Management
2023-11-13Acquired
2022-09-12Series C· $90M
2022-01-10Grant
Leadership Team
Recent News
2025-12-24
Company data provided by crunchbase